Johnson & Johnson's new antidepressant could face structural barriers to uptake - MedCity News

Submitted by Anonymous (not verified) on Sun, 08/04/2019 - 20:26

Johnson & Johnson's new antidepressant could face structural barriers to uptake  MedCity NewsA drug approved five months ago for treating major depressive disorder could face roadblocks due to the way it's administered and current practice patterns by ...